Recommendations Financial News

₹1,092.26 crore IPO of Fedbank Financial Services, a retail-focused non-banking finance company promoted by Federal Bank, continued to witness subdued interest from investors on its second day of bidding. Also Read: Fedbank Financial Services IPO: Issue receives tepid response from investors on Day 01 Investors bid for 5,05,84,571 shares on the second day (November 23) against the available 5,59,23,660 shares, translating into a subscription rate of 90%, as per BSE data. Notably, the retail segment exhibited decent demand as the subscription rate reached 1.26 times.

India needs an additional 2.4 million (24 lakh) hospital beds to reach the recommended ratio of 3 beds per 1,000 people, fuelling the demand for healthcare-related real estate space, according to Knight Frank. Currently, India has an estimated 70,000 hospitals, of which 63 per cent are from the private sector, global real estate consultant Knight Frank and US-based Berkadia said in their report released on Thursday. «India is facing a deficit of 2 billion sq ft of healthcare space to cater to its current population base of 1.42 billion people,» Knight Frank India said in a statement.

Nifty on Thursday ended 10 points lower near the crucial 19,800-zone in an insipid trading session where it failed to break above the hurdle at 19,850. On the derivative front, the strikes of 19,800 saw the highest addition of PE open interest and build-up. The trading day closed with an underperforming market breadth as only 24 out of the Nifty 50 stocks closed in the green, said Avdhut Bagkar Technical and Derivatives Analyst, StoxBox. What should traders do? Here’s what analysts said: Jatin Gedia, Sharekhan The structure is still positive and unless it does not breach below 19,700 we can expect the Nifty to target 19,930 from a short-term perspective.

Nifty Bank index bounced back on Thursday supported by buying seen in key index heavyweights such as HDFC Bank, SBI. The index rose over 100 points to close at 43,577. It hit an intraday high of 43,649 and an intraday low of 43,451.

BSE SME. The refund process will begin on Friday, November 24, and shares will be credited to the Demat account of those allotted on Tuesday, November 28.

HDFC Securities, in its latest report, initiated coverage on Sai Silks (Kalamandir) with a 'buy' recommendation, setting a target price of ₹385 apiece. This target price implies an upside of 36% for the stock from its previous closing price of ₹285 apiece. Launched in FY05, Sai Silks (Kalamandir) Ltd (SSKL) is one of the largest apparel retailers in south India, offering products across ethnic wear (sarees) and value fashion.

We don’t support this browser anymore. This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

We don’t support this browser anymore. This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

We don’t support this browser anymore. This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

TMC MP Mahua Moitra, party chief Mamata Banerjee on Thursday said that plans were in the works to expel her from Parliament but any such action would help the lawmaker from Krishnanagar ahead of the 2024 Lok Sabha elections. Last week, Moitra, who is facing recommendations for expulsion from Lok Sabha, was tasked with strengthening the party's organisation in Nadia district, in a clear message of support from the TMC.

Cochin Shipyard Ltd has been able to successfully ride the recent traction in defence stocks, gaining more than 120% over the past six months. A healthy order pipeline and better-than-anticipated Ebitda margin in the first half of FY24 has further fuelled sentiment for the stock. The growth trajectory of the state-owned shipbuilder hinges on defence orders, especially those from the Indian Navy.

₹370, indicating a downside of over 21 percent. The stock has gained 23.5 percent in the last 1 year. It hit its record high of ₹584 on September 11, 2023, but has shed over 19 percent from its peak.

Rahul Sharma, Director, JM Financial Services, says “unless and until Bank Nifty does not see a major short covering, we will see this slow, gradual up move to continue in Nifty. Testament to this is the midcap and smallcap indices which have created a new high, Nifty is expected to follow suit. So the broader market is not giving up and that is giving us confidence that eventually the ceiling should be taken out and on an immediate basis, 20,000 is what we are expecting the Nifty to test.” On Nifty, clearly we just touch 19,800 and then we see a fall coming in. What is the view coming in for the benchmark indices? Where can we expect it to sustain above 19800? Is that something we could expect to see going forward as well as now? Today's move could be because of the expiry data that we have and this indicates that probably in a day or two, Nifty should be taking on that ceiling of 19850 odd. The way we are reading things is either we close above the 19850 mark or there is a considerable dip which becomes a buying opportunity.

Cipla fell as much as 8% in intraday trade on Thursday following a warning letter by the USFDA for various manufacturing lapses at its Pithampur facility. After an inspection at the Pithampur plant, the USFDA issued a warning letter stating that the company's methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to good manufacturing practices and that its drug products are adulterated. A warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations. «Your firm failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications, whether or not the batch has already been distributed,» the USFDA said. It also pointed out the company's failure to establish and follow appropriate written procedures that are designed to prevent microbiological contamination of drugs purporting to be sterile, and that include validation of all aseptic and sterilization processes. USFDA noted that it has cited similar CGMP observations earlier at the company's other facilities as well. The shares of the company delivered moderate returns to investors so far this year, rising 10% on a year-to-date basis. Despite the pressure in the near term, analysts are bullish on the stock and investors could use this opportunity of declines to consider some buying. Cipla posted strong second-quarter results, led by robust growth across key businesses.

PRAGUE (Reuters) -Czech gunmaker Colt CZ Group has made an offer to Vista Outdoor (NYSE:VSTO), valuing the U.S. sporting and outdoor goods group at about $1.7 billion, according to Reuters calculations.

Escorts, all other companies under our coverage were largely in line with or beat our estimates," stated the brokerage. Meanwhile, for the auto ancillaries space, the brokerage informed that the companies under its coverage reported revenue, EBITDA, and PAT growth of 12 percent, 18 percent, and 18 percent YoY, respectively, driven by higher ASPs, sales volumes, and operating leverage. “All companies under our coverage reported in-line EBITDA or beat on EBITDA, except a miss for Endurance Technologies and CIE Automotive," added Axis.

Stock market today: Yes Bank shares have been in uptrend after Diwali 2023. On the following session post-Muhurat trading, Yes Bank shares opened flat but soon witnessed sharp upside movement when it informed Indian stock market bourses about receipt of ₹120 crore fro sale of NPA portfolio to JC Flowers ARC.

AustralianSuper has blasted attempts by Brookfield to “buy more time” on its $18.7 billion bid for Origin Energy, describing an alternative deal asa “low-ball offer” that would shortchange investors in favour of a private equity consortium.

GMP: The company's shares in the grey market are trading at a healthy premium of ₹73, indicating an over 43 percent premium at listing. However, one must note that grey market premium is only an indicator of how the company's shares are performing in the unlisted market and can change quickly. The ₹501 crore IPO of Gandhar Oil opened for subscription on November 22 and will close on November 24.

Rekha Jhunjhunwala portfolio: Shares of Titan Company Ltd has been in uptrend in last one month. In this time, Titan share price has ascended around ₹200 per share, which fueled Rekha Jhunjhunwala net worth by over ₹950 crore.

₹451 apiece to ₹821.40. Despite a subdued start in January with a 4.4% decline, the stock gained momentum from February onward, marking a substantial 30.26% increase. This positive trend has persisted into November, with the stock already registering a 17% uptick this month.